5 registrations that name magnesium glycinate as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 5 registrations
Status
Phase
1US sites across 1 state
1
2 to 4
5 to 19
20 or more
All 5 registrations
RecruitingNCT07640685
UCLA Magnesium Formulation Athlete Study
No phase
University of California, Los Angeles
About 150 people
Started Oct 5, 2026
In plain words A study of magnesium glycinate in people 18 to 35, run by University of California, Los Angeles. It plans to enroll about 150 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 35; healthy volunteers accepted. Conditions: Athletic Performance; Recovery; Sleep.
Age 18-35 years.
Current NCAA Division I athlete at UCLA.
Actively participating in team training and/or competition.
Willing to wear a WHOOP 4.0 device continuously during the baseline and treatment periods of the study block.
4 more inclusion criteria and the exclusion criteria are on the listing.
This randomized, double-blind, placebo-controlled trial will compare magnesium glycinate, magnesium L-threonate, and placebo in UCLA varsity athletes. Participants will complete a baseline monitoring period followed by 4 weeks of blinded nightly supplementation. WHOOP 4.0 data will be used to evaluate sleep efficiency, total sleep time, sleep consistency, heart rate variability, resting heart rate, and recovery metrics. Baseline and final testing will assess selected reaction and physical performance outcomes. The full summary is on the listing.
Where, as registered
1 US site in 1 state.
RecruitingNCT07655817
Oral Versus Intravenous Magnesium on Emergence Delirium
Phase 2 and 3
Tanta University
About 360 people
Started Jul 1, 2026
In plain words A Phase 2 and 3 study of magnesium glycinate in people 4 to 7, run by Tanta University. It plans to enroll about 360 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 4 to 7. Conditions: Magnesium; Emergence Delirium; Children; Adenotonsillectomy.
Children aged 4 to 7 years
American Society of Anesthesiologist (ASA) Status I or II
Planned for an adenotonsillectomy procedure under sevoflurane general anesthesia.
The exclusion criteria are on the listing.
What it tests, as registered
Magnesium glycinate; Magnesium sulfate injection; Oral juice and intravenous saline
Registered summary
This prospective randomized controlled study will be conducted to compare the effects of preoperative oral magnesium and intraoperative IV magnesium on the incidence and severity of emergence delirium in children undergoing adenotonsillectomy using sevoflurane anesthesia.
Where, as registered
No US site; Egypt (1).
RecruitingNCT07585045
Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment
No phase
Shaikh Zayed Hospital, Lahore
About 86 people
Started Apr 16, 2026
In plain words A study of magnesium glycinate in people 18 to 65, run by Shaikh Zayed Hospital, Lahore. It plans to enroll about 86 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 65. Conditions: Fibromyalgia.
Patients diagnosed with FM according to the American College of Rheumatology (ACR) 2016 criteria
Age: 18-65 years.
Not responding to conventional treatment (e.g., amitriptyline, duloxetine, pregabalin) for at least 8 weeks
Patients giving informed consent for enrollment in the study.
The exclusion criteria are on the listing.
What it tests, as registered
Magnesium glycinate; Vitamins
Registered summary
Fibromyalgia is a complex widespread pain disorder. OBJECTIVES To evaluate the effectiveness of oral magnesium supplementation in reducing symptom severity among fibromyalgia patients who have not responded to standard treatment, using validated scoring systems such as the Fibromyalgia Impact Questionnaire Revised (FIQR).
Where, as registered
No US site; Pakistan (1).
RecruitingNCT07633080
Magnesium Bisglycinate in Major Depressive Disorder
No phase
All India Institute of Medical Sciences, Bhubaneswar
About 84 people
Started Jun 12, 2026
In plain words A study of magnesium glycinate in people 18 to 65, run by All India Institute of Medical Sciences, Bhubaneswar. It plans to enroll about 84 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 65. Conditions: Major Depressive Disorder.
Patients with a diagnosis of Major Depressive Disorder (MDD) as per DSM-5 criteria.
Patients of either sex within the age group of 18-65 years.
Mild to severe depression, defined as a baseline MADRS score ≥7.
Currently receiving a stable dose of antidepressant monotherapy (SSRI or SNRI) in equivalent doses.
1 more inclusion criterion and the exclusion criteria are on the listing.
Depression is a common illness that can affect a person's mood, sleep, energy, ability to work, and overall quality of life. While medicines are available to treat depression, many people do not get complete relief from their symptoms. This study will evaluate whether adding a magnesium supplement in the form of magnesium bisglycinate to regular antidepressant treatment can help improve symptoms of depression. The full summary is on the listing.
Where, as registered
No US site; India (1).
RecruitingNCT06996171
Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
No phase
CMH Kharian Medical College
About 60 people
Started May 5, 2025
In plain words A study of magnesium glycinate in people 18 to 40, run by CMH Kharian Medical College. It plans to enroll about 60 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 40. Conditions: Primary Insomnia.
Age 18-40 years
Gender: Male and Females (Non-pregnant \& Non lactating)
Diagnosed cases of primary insomnia according to following criteria:
Difficulty falling asleep, staying asleep or nonrestorative sleep
3 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Magnesium glycinate; Melatonin
Registered summary
Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.